Related Experiment Video

Updated: Apr 16, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

2.0K

Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer

Matthew Howell1, Rebecca Lee2, Samantha Bowyer1

  • 1The Christie NHS Foundation Trust, Wilmslow Road, Manchester M21 4BX, United Kingdom.

Lung Cancer (Amsterdam, Netherlands)
|March 18, 2015
PubMed

Insights

Immune checkpoint inhibitors like CTLA-4, PD-1, and PD-L1 antibodies are used in lung cancer but cause unique immune-related toxicities. Prompt recognition and management are crucial for patient safety.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Immune checkpoint inhibitors targeting CTLA-4, PD-1, and PD-L1 are now standard in lung cancer treatment.
  • These therapies introduce novel immune-related adverse events (irAEs) not seen with traditional lung cancer treatments.

Purpose of the Study:

  • To review common immune-related toxicities associated with immune checkpoint inhibitors in lung cancer.
  • To provide evidence-based recommendations for the prompt management of these toxicities.

Main Methods:

  • Literature review of immune checkpoint inhibitor-related toxicities in lung cancer.
  • Analysis of reported adverse events and current management strategies.

Main Results:

  • Common irAEs include colitis, hepatitis, rash, and neuropathies.
  • While often low-grade, irAEs can become severe or life-threatening if not managed promptly.

Conclusions:

  • Early identification and standardized management protocols for irAEs are essential for patient safety in lung cancer immunotherapy.
  • Effective management strategies can mitigate the risks associated with these novel lung cancer therapies.
Keywords:
Anti-CTLA-4Anti-PD-1Anti-PD-L1ImmunotherapyLung cancerToxicity

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K